(2026). Visual Gains with Faricimab vs Aflibercept 8 mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review. Clinical Ophthalmology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Visual Gains with Faricimab Vs Aflibercept 8 Mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review."
Clinical Ophthalmology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Visual Gains with Faricimab Vs Aflibercept 8 Mg in Naïve Retinovascular Disease: Global Real-World Cases and Literature Review."
Clinical Ophthalmology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.